Christopher W. Krueger, SVP & CBO at Ardea Biosciences, Inc./DE (RDEA), sold 9,000 shares at $18.45 ($166K) on 2010-03-23, disclosed to the SEC on 2010-03-24.
Scheduled sale ($166k) by SVP & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |